20152023 World Alzheimer's Disease Drug Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 16012018] Prices from USD $2800
Summary
Alzheimer's disease AD, also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region / Countries
North America U.S., Canada, Mexico
Europe Germany, U.K., France, Italy, Russia, Spain etc
South America Brazil, Argentina etc
Middle East Africa Saudi Arabia, South Africa etc
By Type
Donepezil
Memantine
Rivastigmine
By EndUser / Application
Early to Moderate Stages
Moderate to Severe Stages
By Company
Lundbeck.
Merz Pharma
Daiichi Sankyo
Johnson Johnson
Novartis
Allergan
Pfizer
